SHARE

Dr Martens maintains FY27 outlook amid strong US wholesale performance

The footwear brand kept its full-year outlook unchanged ahead of its annual meeting. Profit before tax rose 9.7% to £32.7m, supported by strong wholesale performance in the US and solid trading across key international markets.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.